Sam Lee
CIK: 0001602074
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
COCP
Cocrystal Pharma, Inc.
Officer
Discretionary Trading P&L
Holdings
About Lee Sam
Lee Sam (SEC CIK 0001602074) files insider reports with the SEC as President and Co-CEO of Cocrystal Pharma, Inc. (COCP).
Signal8 holds 2 ownership filings by Lee Sam, all Form 4s, filed between Oct 11, 2024 and Jan 13, 2026. Those filings report 2 transactions, from Oct 9, 2024 to Jan 9, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Lee Sam's filings is in BOTHELL, WA.
Recent filings by Lee Sam
Other insiders filing for Cocrystal Pharma, Inc. (COCP)
- Brosgart Carol L, Director
- FROST PHILLIP MD ET AL, Director
- SAPIRSTEIN JAMES, Chief Executive Officer
- Kornberg Roger D., Director
- PFENNIGER RICHARD C JR, Director
- Hassan Fred, Director